BIOCON
Back to Cashflow Statement
|
BIOCON Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-924 Cr | ₹-1,854 Cr | ₹-2,333 Cr | ₹13,049 Cr | ₹242 Cr |
What is the latest Cash Flow from Financing Activities ratio of BIOCON ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-924 Cr |
| Mar2025 | ₹-1,854 Cr |
| Mar2024 | ₹-2,333 Cr |
| Mar2023 | ₹13,049 Cr |
| Mar2022 | ₹242 Cr |
How is Cash Flow from Financing Activities of BIOCON Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-924 Cr | Negative | |
| Mar2025 | ₹-1,854 Cr | Negative | |
| Mar2024 | ₹-2,333 Cr | Negative | |
| Mar2023 | ₹13,049 Cr | 5,289.80 | |
| Mar2022 | ₹242 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹67,616.3 Cr | -3.5% | -5.9% | 14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -3.5% |
-5.9% |
14.1% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses